Tuesday’s Midday Stock Update: American Green Inc (ERBB), SunPower Corp (SPWR), NovaBay Pharma (NBY), Conatus Pharmaceuticals (CNAT), Medical Marijuana Inc (MJNA)

By Carrie Williams

So far Tuesday, June 18, NASDAQ is up 1.71% and the S&P is up 0.86%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; American Green Inc (ERBBResearch Report), SunPower Corp (SPWRResearch Report), NovaBay Pharma (NBYResearch Report), Conatus Pharmaceuticals (CNATResearch Report) and Medical Marijuana Inc (MJNAResearch Report).

American Green Inc is up 50% in midday trading to $0.00. Shares opened today at $0.00. The company has a 52-week low of $0.00 and a 52-week high of $0.00.

SunPower Corp is up 20.87% in midday trading to $10.64. Shares opened today at $8.80. The company has a 52-week low of $4.55 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $8.00, marking a -9.09% potential downside from current levels. In a report released yesterday, Goldman Sachs analyst Brian K. Lee upgraded SPWR to Buy, with a price target of $11, which represents a potential upside of 25% from where the stock is currently trading. Separately, on May 9, Oppenheimer’s Colin Rusch maintained a Hold rating on the stock .

NovaBay Pharma is up 12.52% in midday trading to $1.82. Shares opened today at $1.62. The company has a 52-week low of $0.23 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $1.00, marking a -38.27% potential downside from current levels. In a report issued on March 29, H.C. Wainwright analyst Ram Selvaraju reiterated a Hold rating on NBY, with a price target of $1, which implies a downside of 38% from current levels. In the last 30 days, insiders have sold $1.72M worth of NBY shares. Over the last 3 months, the insider sentiment on NovaBay Pharma has been negative based on 3 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

See today’s analyst top recommended stocks >>

Conatus Pharmaceuticals is up 12.18% in midday trading to $0.82. Shares opened today at $0.74. The company has a 52-week low of $0.69 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $1.60, marking a 117.69% potential upside from current levels. In a report issued on May 3, H.C. Wainwright analyst Ed Arce maintained a Hold rating on CNAT, with a price target of $1.50, which represents a potential upside of 104% from where the stock is currently trading.

See today’s analyst top recommended stocks >>

Medical Marijuana Inc is down -11.33% in midday trading to $0.05. Shares opened today at $0.06. The company has a 52-week low of $0.04 and a 52-week high of $0.00.

Trending Stocks Based on Insider Activity >>